Clinical Trials Logo

Clinical Trial Summary

The primary objective of the study is to examine whether there is a difference in disability after 12 months of Spinal Cord Stimulation (SCS) in patients with Persistent Spinal Pain Syndrome Type 2 (PSPS T2) after receiving a standardized pain medication tapering protocol before SCS implantation, a personalized pain medication tapering protocol before SCS implantation, or no tapering protocol before SCS implantation. The secondary objective of the study is to examine whether there is a difference after 12 months of SCS in PSPS T2 patients after receiving a standardized pain medication tapering protocol before SCS implantation, a personalized pain medication tapering protocol before SCS implantation, or no tapering protocol before SCS implantation on pain intensity, health-related quality of life, participation, domains affected by substance use, anxiety and depression, medication use, psychological constructs, sleep, central sensitization, and healthcare expenditure.


Clinical Trial Description

Persistent Spinal Pain Syndrome Type II (PSPS T2) is a condition in which patients are suffering from persistent low back pain, despite previously performed surgical interventions. One way to help patients to alleviate their pain, is with Spinal Cord Stimulation (SCS). SCS is able to provide pain relief and a decrease in disability but also to decrease the amount of pain medication and more specifically opioid intake. Nevertheless, the number of patients that can eventually totally omit the use of opioids is rather limited. In this trial, we will investigate the effect of a pain medication tapering program before starting the SCS trajectory as the new treatment strategy for patients implanted with SCS. This allows us to tackle the high burden of patients that are taking a lot of pain medication by proceeding towards a more logical treatment plan for a costly and debilitating condition. A three-arm multicenter randomized controlled trial will be conducted to evaluate whether there is a difference in disability (primary outcome) after 12 months of SCS in PSPS T2 patients after receiving a standardized pain medication tapering protocol before SCS implantation, a personalized pain medication tapering protocol before SCS implantation, or no tapering protocol before SCS implantation. Two different pain medication tapering programs (standardized versus personalized tapering) will be evaluated in this project. Pain medication tapering will be provided to 130 patients during a hospital stay, compared to 65 patients who do not undergo pain medication tapering before SCS implantation. Besides disability as primary outcome measure, several secondary outcome measurements will be collected namely pain intensity, health-related quality of life, participation, domains affected by substance use, anxiety and depression, medication use, psychological constructs, sleep, central sensitization and health expenditure. Outcome measurements will be collected at baseline, and after 1 month, 3, 6 and 12 months of SCS. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05861609
Study type Interventional
Source Universitair Ziekenhuis Brussel
Contact Maarten Moens, Prof, Dr.
Phone +3224775514
Email stimulusresearchgroup@gmail.com
Status Recruiting
Phase N/A
Start date September 29, 2023
Completion date September 2026

See also
  Status Clinical Trial Phase
Recruiting NCT03462147 - Efficacy of Spinal Cord Stimulation in Patients With a Failed Back Surgery Syndrome. N/A
Recruiting NCT04244669 - Impact of the SCS With Different Waveforms Over the Quality of Life (SCS-Quality) N/A
Recruiting NCT02958423 - tDCS Versus tsDCS for Endometriosis-related Chronic Pelvic Pain Treatment Phase 1/Phase 2
Not yet recruiting NCT05704751 - EVOKE ECAP-Controlled Lead Placement and Programming in Chronic Pain Patients
Completed NCT01126983 - Lead Migration in Spinal Cord Stimulation Trials: Comparing Non-suture vs Suture and Lead Anchor N/A
Recruiting NCT04604951 - Below the Belt: Non-invasive Neuromodulation to Treat Bladder, Bowel, and Sexual Dysfunction Following Spinal Cord Injury N/A
Recruiting NCT05269212 - Return to Work for Persistent Spinal Pain Syndrome Type II Patients N/A
Recruiting NCT05466110 - Spinal Cord Stimulation Versus Instrumentation for FBSS N/A
Withdrawn NCT05794776 - Effect of Spinal Cord Stimulation (SCS) on Insulin Secretion in Humans N/A
Completed NCT05283863 - Direct Comparison of Spinal Cord Stimulator Parameter Settings N/A
Recruiting NCT04785001 - New Markers to Assess the Efficacity of Spinal Cord Stimulation for the Treatment of Chronic Lower Limb Pain (MOTIVE)
Recruiting NCT03179488 - Therapist-dependent Dose of Spinal TENS N/A
Terminated NCT04367116 - The Study to Evaluate the Safety and Efficacy of Spinal Cord Stimulation on Progressive Supranuclear Palsy N/A
Completed NCT03386058 - Examining Carryover Effect in Patients Treated witH Spinal cOrd Stimulation (ECHO) N/A
Recruiting NCT06000592 - Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI N/A
Completed NCT03526055 - Evaluation of Conventional and Long Pulse Widths During a Temporary Spinal Cord Stimulation Trial N/A
Not yet recruiting NCT05712980 - Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation
Recruiting NCT03858790 - Efficacy and Safety of Spinal Cord Stimulation in Patients With Chronic Intractable Pain N/A
Active, not recruiting NCT04960592 - Epigenetic Mechanisms and Symptom Clusters Associated With Resolution of Pain Following Spinal Cord Stimulation
Recruiting NCT05178056 - Spinal Cord Stimulation and Respiration After Injury N/A